Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants
about
Association between anemia and bronchopulmonary dysplasia in preterm infants.Recombinant human erythropoietin improves neurological outcomes in very preterm infants.Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?Erythropoietin for Neuroprotection in preterm infants.
P2860
Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacodynamically optimized ...... ns in selected preterm infants
@ast
Pharmacodynamically optimized ...... ns in selected preterm infants
@en
type
label
Pharmacodynamically optimized ...... ns in selected preterm infants
@ast
Pharmacodynamically optimized ...... ns in selected preterm infants
@en
prefLabel
Pharmacodynamically optimized ...... ns in selected preterm infants
@ast
Pharmacodynamically optimized ...... ns in selected preterm infants
@en
P2093
P2860
P921
P356
P1433
P1476
Pharmacodynamically optimized ...... ns in selected preterm infants
@en
P2093
Demet Nalbant
Gretchen Cress
John A Widness
Matthew R Rosebraugh
Peter Veng-Pedersen
P2860
P2888
P304
P356
10.1038/PR.2013.213
P407
P577
2013-11-11T00:00:00Z